88 results on '"Hamid, Saeed Sadiq"'
Search Results
2. SAT-129 Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
3. THU-078 Extra-hepatic organ failure in ACLF patients is associated with poor survival and limited curative therapy-results from AARC cohort
4. THU-052 Therapeutic plasma-exchange improves short-term survival in patients with ACLF admitted to intensive care unit with organ failures-a multinational AARC data analysis
5. WED-382 Modeling dual antiviral activity of lonafarnib to explain hepatitis D virus RNA negativity 24 weeks after end of therapy despite RNA positivity at end of therapy: The D-LIVR study
6. SAT-438 Fatigue is an Important Driver of Work Productivity Loss and Impairment of Patient-Reported Outcomes (PROs) among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
7. Impact of compensated cirrhosis on survival in patients with acute-on-chronic liver failure
8. ‘First week’ is the crucial period for deciding living donor liver transplantation in patients with acute-on-chronic liver failure
9. Ammonia is associated with liver-related complications and predicts mortality in acute-on-chronic liver failure patients.
10. Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis – prevalence and risk factors
11. Prevalence and predictors of clinically significant pruritus in patients with non-alcoholic fatty liver disease (NAFLD): data from the global NASH registry™ (GNR™)
12. Challenges and strategies to improve linkage to care and treatment for hepatitis C in pregnancy: perspectives from a global community of practice
13. Final results of a hepatitis C micro-elimination campaign in a highly endemic, well-defined demographic area of peri-urban Karachi, Pakistan
14. Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
15. Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
16. The impact of hepatitis C and socio-demographic variables on Health-related quality of life among patients in Pakistan
17. Mathematical modeling of HDV RNA kinetics suggests high peginterferon Lambda efficacy in blocking viral production: insights from the LIMT-1 study
18. Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease
19. A cluster randomized controlled study of secondary distribution of HCV self-test to support micro-elimination in Karachi, Pakistan.
20. Lean non-alcoholic fatty liver disease patients from the global NASH registry
21. Hepatitis C prevalence and elimination in Pakistan; a bottom-up approach accounting for provincial variation
22. Using time to positivity of hepatitis rapid detection test results to determine active viremia
23. Estimating the prevalence of hepatitis delta infection among foreign-born adults with chronic hepatitis B in the United States
24. WED-407 Characterization of hepatitis D virus RNA and hepatitis B surface antigen kinetics during pegylated interferon-alphamonotherapy: The D-LIVR study
25. Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure
26. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
27. FRI-174 - Challenges and strategies to improve linkage to care and treatment for hepatitis C in pregnancy: perspectives from a global community of practice
28. FRI-172 - The impact of hepatitis C and socio-demographic variables on Health-related quality of life among patients in Pakistan
29. FRI-145 - Final results of a hepatitis C micro-elimination campaign in a highly endemic, well-defined demographic area of peri-urban Karachi, Pakistan
30. SAT-125 - Prevalence and predictors of clinically significant pruritus in patients with non-alcoholic fatty liver disease (NAFLD): data from the global NASH registry™ (GNR™)
31. GS-012 - Week 48 results of the phase 3 D-LIVR study, a randomized double-blind, placebo-controlled trial evaluating the safety and efficacy of Lonafarnib-boosted with Ritonavir with or without Peginterferon Alfa in patients with chronic hepatitis delta
32. Implementing work place based assessment: The modified direct observation of procedural skills (DOPS) across medical specialties -- An experience from a developing country.
33. Modelling the cost of hepatitis C virus transmission in Pakistan
34. Dynamic assessments of hepatic encephalopathy and ammonia levels predict mortality in acute-on-chronic liver failure.
35. Comparative accuracy of prognostic models for short-term mortality in acute-on-chronic liver failure patients: CAP-ACLF.
36. Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
37. PS-052-End of study results from LIMT HDV study: 36% durable virologic response at 24 weeks post-treatment with pegylated interferon lambda monotherapy in patients with chronic hepatitis delta virus infection
38. THU-045-Natural history of sepsis, organ failure and organ dysfunction in critically ill patients with acute on chronic liver failure
39. FRI-161-Complication is a major risk factor for mortality of cirrhotic hepatitis B virus-related acuted-on-chronic liver failure patients: A multi-national study from Asian-pacific region
40. THU-053-Usefulness of lactate-free Asian Pacific Association for The Study of Liver acute-on-chronic liver failure research consortium ACLF score for predicting short-term mortality in patient with alcoholic liver disease
41. Duodenal erosions and ulcers in patients with pancreatobiliary obstruction
42. Treatment of people diagnosed with chronic hepatitis C virus infection
43. Yield of esophagogastroduodenoscopy and colonoscopy in cancer of unknown primary
44. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
45. Outcomes of Gastric Variceal Bleed
46. Negative impact of COVID-19 infection related to life disruption events and health scores on patients with chronic liver disease
47. Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis--prevalence and risk factors.
48. THU-279-The prognostic stratification using acute-on-chronic liver failure scoring systems for predicting short-term mortality in patients with alcoholic hepatitis.
49. Implementing work place based assessment: The modified direct observation of procedural skills (DOPS) across medical specialties - An experience from a developing country.
50. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.